2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 6.900.000 | 221.813 | 1 | ||
2020 | 0 | 8.573.895 | 529.910 | 1 |
Total number of partners: 27
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 27
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-02-01 | Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine | TIGER | participant | 6.900.000 | 8 |
2020-04-01 | COMBINING APPROACHES FOR PHOTOSYNTHETIC IMPROVEMENT TO ALLOW INCREASED SUSTAINABILITY IN EUROPEAN AGRICULTURE | CAPITALISE | participant | 8.573.895 | 21 |